
Pharma Pulse 8/30/24: Medication Mistakes Pharmacists Want You to Stop Making, Express Scripts to Remove Humira & more
The latest news for pharma industry insiders.
A Harvard Business School Healthcare Alumni Association Q&A with Dr. Hersh Sagreiya at the Hospital of the University of Pennsylvania.
Beginning in 2025, Express Scripts will favor biosimilars of Humira, including its own private-label version.
Common habits like storing pills in your medicine cabinet can reduce their effectiveness, experts say.
Phreesia and the American Academy of Pediatrics (AAP), have joined forces to increase measles, mumps and rubella (MMR) immunization by reaching parents and caregivers of eligible or soon-to-be eligible children at the point of care. The collaboration comes as immunization rates have dipped in some communities, pointing to a need to improve access to the vaccines that can help keep children healthy.
My thanks to HDA - Healthcare Distribution Alliance and all the fantastic attendees and panelists for another great traceability seminar!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

